Efficacy of sustained release morphine and immediate release morphine for treatment of cancer pain a comparative study
Phase 2
- Conditions
- Health Condition 1: C00-D49- Neoplasms
- Registration Number
- CTRI/2022/01/039252
- Lead Sponsor
- Gaurav Sharma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Analgesics regimen >60mg/day of orally given morphine
2. Life expectancy <6 months
3. written informed consent
Exclusion Criteria
1. Patient refusal for consent.
2. Chemotherapy or radiotherapy that didnâ??t allow accurate dose titration of morphine
3. Impaired bowel mobility or intractable vomiting
4. Inability to swallow whole capsule
5. History of respiratory depression
6. History of allergy to proposed/used drugs in the study
7. Patients with multiple organ failure
8. Inability to comply with protocol.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare VAS scores of two groupsTimepoint: 2 weeks
- Secondary Outcome Measures
Name Time Method To compare patient complianceTimepoint: 7 days